Speakers
Sample of Keynote Speakers and their Case Studies
CASE STUDY
Reimagining Global Medical Information: From Service to Strategic Impact
Global Medical Information is evolving from a reactive service to a strategic driver within Medical Affairs. This session explores how GMI can generate actionable insights, leverage digital and AI capabilities, and enable better decision-making across the organisation. We will highlight key enablers, organisational shifts, and practical approaches to unlock greater impact, positioning GMI as a critical contributor to scientific leadership and patient outcomes.
- 01From reactive answers to proactive insights
- 02Data, digital, and Al as key enablers
- 03Better, faster Medical Affairs decisions
- 04Integrated omnichannel engagement
- 04Impact over volume metrics
CASE STUDY
Designing With, Not For: The Future of Patient Partnership in Medical Affairs
This session challenges Medical Affairs professionals to turn patient centricity from a guiding principle into a measurable practice — across how activities are designed, evidence is built, and outcomes are evaluated.
- 01Learn from experience: Explore what authentic co-creation with patients and advocacy groups truly requires — drawing on real-world examples
- 02Challenge the status quo: Examine where patient voice is genuinely shaping evidence and communications, and where critical gaps remain
- 03Build for impact: Begin establishing a practical framework to identify, address, and measure what real patient impact looks like in your organisation
CASE STUDY
How Can We Achieve True Patient Collaboration in Medical Affairs?
What do we mean by true patient collaboration? Why are medical affairs best placed to collaborate with patients? What are some of the challenges in true patient collaboration? What are the advantages of true patient collaboration? What could be some of the ways we can achieve this in the industry?
- 01Definition of patient engagement
- 02Why medical affairs
- 03Some challenges in true collaboration
- 04Some benefits of true patient collaboration
- 05What are we doing now and what can we do more of
CASE STUDY
Medical Affairs Strategy and Implementation – Adapt with Commercialisation Model
- 01Adapting Medical Affairs strategies to different commercialisation models
- 02Building and managing effective Medical Affairs capabilities within partner and distributor networks
- 03Supporting successful launches and lifecycle management (LCM) of specialty and rare disease products
- 04Ensuring scientific consistency, compliance, and stakeholder engagement across multiple markets
- 05Lessons learned and best practices from global and regional implementation
CASE STUDY
Which KPIs Actually Prove Impact to Leadership?
Despite a decade long discussion, no true standards to measure the value and impact of Medical Affairs beyond measuring quantity (e.g. number of MSL interactions, number of publications) are established. Capturing clinical adoption and closing of care gaps as ultimate goals remains elusive for most companies. This presentation will focus on a framework with the pillars from activity metrics to changes in knowledge/beliefs/ behaviour to impact on patient outputs and outcomes including examples and interactive discussions.
- 01KPI framework
- 02Patient impact measurement
- 03Case discussions
- 04Implementation and pitfalls
CASE STUDY
Reimagining Global Medical Information: From Service to Strategic Impact
Global Medical Information is evolving from a reactive service to a strategic driver within Medical Affairs. This session explores how GMI can generate actionable insights, leverage digital and AI capabilities, and enable better decision-making across the organisation. We will highlight key enablers, organisational shifts, and practical approaches to unlock greater impact, positioning GMI as a critical contributor to scientific leadership and patient outcomes.
- 01From reactive answers to proactive insights
- 02Data, digital, and Al as key enablers
- 03Better, faster Medical Affairs decisions
- 04Integrated omnichannel engagement
- 04Impact over volume metrics
CASE STUDY
Designing With, Not For: The Future of Patient Partnership in Medical Affairs
This session challenges Medical Affairs professionals to turn patient centricity from a guiding principle into a measurable practice — across how activities are designed, evidence is built, and outcomes are evaluated.
- 01Learn from experience: Explore what authentic co-creation with patients and advocacy groups truly requires — drawing on real-world examples
- 02Challenge the status quo: Examine where patient voice is genuinely shaping evidence and communications, and where critical gaps remain
- 03Build for impact: Begin establishing a practical framework to identify, address, and measure what real patient impact looks like in your organisation
CASE STUDY
How Can We Achieve True Patient Collaboration in Medical Affairs?
What do we mean by true patient collaboration? Why are medical affairs best placed to collaborate with patients? What are some of the challenges in true patient collaboration? What are the advantages of true patient collaboration? What could be some of the ways we can achieve this in the industry?
- 01Definition of patient engagement
- 02Why medical affairs
- 03Some challenges in true collaboration
- 04Some benefits of true patient collaboration
- 05What are we doing now and what can we do more of
CASE STUDY
Medical Affairs Strategy and Implementation – Adapt with Commercialisation Model
- 01Adapting Medical Affairs strategies to different commercialisation models
- 02Building and managing effective Medical Affairs capabilities within partner and distributor networks
- 03Supporting successful launches and lifecycle management (LCM) of specialty and rare disease products
- 04Ensuring scientific consistency, compliance, and stakeholder engagement across multiple markets
- 05Lessons learned and best practices from global and regional implementation
CASE STUDY
Which KPIs Actually Prove Impact to Leadership?
Despite a decade long discussion, no true standards to measure the value and impact of Medical Affairs beyond measuring quantity (e.g. number of MSL interactions, number of publications) are established. Capturing clinical adoption and closing of care gaps as ultimate goals remains elusive for most companies. This presentation will focus on a framework with the pillars from activity metrics to changes in knowledge/beliefs/ behaviour to impact on patient outputs and outcomes including examples and interactive discussions.
- 01KPI framework
- 02Patient impact measurement
- 03Case discussions
- 04Implementation and pitfalls
CASE STUDY
Reimagining Global Medical Information: From Service to Strategic Impact
Global Medical Information is evolving from a reactive service to a strategic driver within Medical Affairs. This session explores how GMI can generate actionable insights, leverage digital and AI capabilities, and enable better decision-making across the organisation. We will highlight key enablers, organisational shifts, and practical approaches to unlock greater impact, positioning GMI as a critical contributor to scientific leadership and patient outcomes.
- 01From reactive answers to proactive insights
- 02Data, digital, and Al as key enablers
- 03Better, faster Medical Affairs decisions
- 04Integrated omnichannel engagement
- 04Impact over volume metrics
CASE STUDY
Designing With, Not For: The Future of Patient Partnership in Medical Affairs
This session challenges Medical Affairs professionals to turn patient centricity from a guiding principle into a measurable practice — across how activities are designed, evidence is built, and outcomes are evaluated.
- 01Learn from experience: Explore what authentic co-creation with patients and advocacy groups truly requires — drawing on real-world examples
- 02Challenge the status quo: Examine where patient voice is genuinely shaping evidence and communications, and where critical gaps remain
- 03Build for impact: Begin establishing a practical framework to identify, address, and measure what real patient impact looks like in your organisation
CASE STUDY
How Can We Achieve True Patient Collaboration in Medical Affairs?
What do we mean by true patient collaboration? Why are medical affairs best placed to collaborate with patients? What are some of the challenges in true patient collaboration? What are the advantages of true patient collaboration? What could be some of the ways we can achieve this in the industry?
- 01Definition of patient engagement
- 02Why medical affairs
- 03Some challenges in true collaboration
- 04Some benefits of true patient collaboration
- 05What are we doing now and what can we do more of
CASE STUDY
Medical Affairs Strategy and Implementation – Adapt with Commercialisation Model
- 01Adapting Medical Affairs strategies to different commercialisation models
- 02Building and managing effective Medical Affairs capabilities within partner and distributor networks
- 03Supporting successful launches and lifecycle management (LCM) of specialty and rare disease products
- 04Ensuring scientific consistency, compliance, and stakeholder engagement across multiple markets
- 05Lessons learned and best practices from global and regional implementation
CASE STUDY
Which KPIs Actually Prove Impact to Leadership?
Despite a decade long discussion, no true standards to measure the value and impact of Medical Affairs beyond measuring quantity (e.g. number of MSL interactions, number of publications) are established. Capturing clinical adoption and closing of care gaps as ultimate goals remains elusive for most companies. This presentation will focus on a framework with the pillars from activity metrics to changes in knowledge/beliefs/ behaviour to impact on patient outputs and outcomes including examples and interactive discussions.
- 01KPI framework
- 02Patient impact measurement
- 03Case discussions
- 04Implementation and pitfalls